P53 autoantibodies in 1006 patients followed up for breast cancer

AUTOR(ES)

Metcalfe, Su

FONTE

BioMed Central

RESUMO

Serial plasma samples from 1006 patients with breast cancer revealed: (i) no correlation of p53 autoantibody status with disease status at the time of sample collection, or with menopausal status at time of primary diagnosis of breast cancer; (ii) 155 out of 1006 (15%) of patients were positive for p53 autoantibodies, and these patients tended to have a persistent autoantibody status throughout follow up, irrespective of disease behaviour; and (iii) where a negative autoantibody status was found at primary diagnosis of breast cancer, this negative status persisted throughout follow up, irrespective of later disease behaviour. We conclude that screening for p53 autoantibody status is not informative on residual tumour activity nor on therapeutic responsiveness.

Documentos Relacionados

• The p53 pathway in breast cancer
• Genetic basis for p53 overexpression in human breast cancer.
• Mutations in p53 as potential molecular markers for human breast cancer.
• Mutant p53 mediates survival of breast cancer cells
• Nonisotopic SSCP and competitive PCR for DNA quantification: p53 in breast cancer cells.